Drug intelligence / Profile preview

cinoxate

Development stage
Unknown
Modality
Small Molecules
Administration
Topical
01

Overview

Cinoxate is a synthetic organic compound classified as an ester, specifically formed from methoxycinnamic acid and 2-ethoxyethanol. It appears as a slightly yellow viscous liquid that is insoluble in water but miscible with alcohols, esters, and vegetable oils[7][8]. Cinoxate functions primarily as a sunscreen agent by absorbing ultraviolet (UV) radiation—especially in the UVB range (280–320 nm)—thereby protecting skin cells from sunburn, photoaging, and DNA damage that can lead to skin cancer[1][6][8]. It was first approved by the United States Food and Drug Administration (FDA) in 1961 for use as an active ingredient in over-the-counter sunscreen products at concentrations up to 3%[1][5][7]. Although effective at absorbing UV rays and reducing risks associated with sun exposure, its use has declined over time and it is now rarely found in modern cosmetic formulations[7][8]. There are also reports of potential photoallergic contact dermatitis associated with its use[5].

Other names
2-ethoxyethyl-p-methoxycinnamatecinoxatocinoxatum

Beyond the preview

Go deeper on cinoxate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on cinoxate.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call